Castelnau Group Limited (CGL.L)
GBp 94.0
(0.0%)
GBp 94.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | -904.73 Thousand | -33 Million | -9.47 Million |
| Cost of Revenue | 135.11 Thousand | 91.56 Thousand | - |
| Gross Profit | -1.03 Million | -33.09 Million | -9.47 Million |
| Operating Expenses | -904.73 Thousand | 1.08 Million | 2.51 Million |
| Selling, General and Administrative Expenses | 3.15 Million | 788.49 Thousand | 2.51 Million |
| Research and Development Expenses | - | - | - |
| Other Expenses | -4.06 Million | 299.14 Thousand | - |
| Cost and Expenses | 1.21 Million | 1.08 Million | 2.51 Million |
| Operating Income | -1.57 Million | -34.09 Million | -11.98 Million |
| Interest Expense | 10.71 Million | - | 400.00 |
| Income Tax Expense | 3081.00 | 2889.00 | -11.98 Million |
| Earnings before Tax | -7.77 Million | -34.09 Million | -11.98 Million |
| Net Income | -7.77 Million | -34.09 Million | -11.98 Million |
| Earnings Per Share Basic | -0.03 | -0.19 | -0.07 |
| Earnings Per Share Diluted | -0.03 | -0.19 | -0.07 |
| Weighted Average Shares Outstanding | 274.37 Million | 183.99 Million | 182.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 274.36 Million | 183.99 Million | 182.57 Million |
| Gross Margin | 1.15 | 1.00 | 1.00 |
| EBIT Margin | 1.89 | 1.03 | 1.27 |
| Profit Margin | 8.59 | 1.03 | 1.27 |
| EBITDA | -1.7 Million | - | -9.42 Million |
| Earnings Before Tax Margin | 1.74 | 1.03 | 1.27 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 447.21 Thousand | 447.21 Thousand | -904.73 Thousand | 512.66 Thousand | 512.66 Thousand | 483.38 Thousand |
| Cost of Revenue | 34.17 Thousand | 34.17 Thousand | 135.11 Thousand | 35.34 Thousand | 35.34 Thousand | 32.21 Thousand |
| Gross Profit | 413.03 Thousand | 413.03 Thousand | -1.03 Million | 477.32 Thousand | 477.32 Thousand | 451.16 Thousand |
| Operating Expenses | 540.83 Thousand | 540.83 Thousand | 6.86 Million | 507.1 Thousand | 5.27 Million | 4.73 Million |
| Selling, General and Administrative Expenses | 540.83 Thousand | 540.83 Thousand | - | 507.1 Thousand | 507.1 Thousand | 1.21 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 575.01 Thousand | 575.01 Thousand | 1.21 Million | 542.45 Thousand | 5.3 Million | 4.76 Million |
| Operating Income | -127.8 Thousand | -127.8 Thousand | -1.7 Million | -29.78 Thousand | -65.41 Thousand | -788.1 Thousand |
| Interest Expense | - | - | 10.71 Million | - | - | - |
| Income Tax Expense | -40.47 Thousand | -40.47 Thousand | 3081.00 | 1541.00 | 1541.00 | -6.86 Million |
| Earnings before Tax | 42.89 Million | 42.89 Million | -7.77 Million | 3.76 Million | 3.76 Million | -7.65 Million |
| Net Income | 42.89 Million | 42.89 Million | -7.77 Million | 3.76 Million | 3.76 Million | -7.65 Million |
| Earnings Per Share Basic | 0.13 | 0.13 | - | 0.01 | 0.01 | -0.03 |
| Earnings Per Share Diluted | 0.13 | 0.13 | - | 0.01 | 0.01 | -0.03 |
| Weighted Average Shares Outstanding | 318.82 Million | 318.82 Million | 274.37 Million | 319.37 Million | 319.37 Million | 229.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 318.82 Million | 318.82 Million | 274.36 Million | 319.36 Million | 319.36 Million | 229.36 Million |
| Gross Margin | 0.92 | 0.92 | 1.15 | 0.93 | 0.93 | 0.93 |
| EBIT Margin | -0.38 | -0.38 | - | -0.13 | -0.13 | -14.20 |
| Profit Margin | 95.91 | 95.91 | 8.59 | 7.34 | 7.34 | -15.83 |
| EBITDA | -168.12 Thousand | -168.12 Thousand | - | -65.26 Thousand | -65.11 Thousand | -6.86 Million |
| Earnings Before Tax Margin | -0.29 | -0.29 | 1.89 | -0.06 | -0.13 | -1.63 |
301006
1770
AHCHF
300686
AREXMIS
000788